Narcolepsy Drugs Market Players:
- Ligand Pharmaceuticals Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Jazz Pharmaceuticals Inc.
- Graymark Healthcare Inc.
- BIOPROJET
- Novartis AG
- Teva Pharmaceuticals Industries Ltd.
- Arena Pharmaceuticals Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of narcolepsy drugs is assessed at USD 3.72 billion.
The global narcolepsy drugs market size was valued at more than USD 3.44 billion in 2025 and is expected to register a CAGR of over 9.2%, exceeding USD 8.29 billion revenue by 2035.
North America narcolepsy drugs market will dominate over 42.2% share by 2035, driven by rising prevalence of unhealthy lifestyles and technological advancements in diagnosis.
Key players in the market include Ligand Pharmaceuticals Incorporated, Jazz Pharmaceuticals Inc., Graymark Healthcare Inc., BIOPROJET, Novartis AG, Teva Pharmaceuticals Industries Ltd., Arena Pharmaceuticals Inc.
